Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON29706
NL-OMON29706
Not yet recruiting
Not Applicable

Assessment of cardio vascular risk by measurement of carotid intima-media thickness (cIMT) in adult type I Gaucher disease patients. - Intima media thickness in Gaucher type I disease.

Academisch Medisch Centrum0 sites140 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGaucher disease type Iglucocerebrosidase deficiency10027424

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gaucher disease type I
Sponsor
Academisch Medisch Centrum
Enrollment
140
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\-Patients, older than 18 years, with proven GD I, as evidenced by decreased plasma glucocerebrosidase activity or genotyping.
  • •\-Carriers, older than 18 years, with proven heterozygosity for the GD I genotype.
  • •\-Controls, older than 18 years, with proven absence of the four most prevalent Gaucher\-mutations, and, if related to a Gaucher patient, absence of the Gaucher mutations present in their family.
  • •\-Patients, carriers and controls have to provide written informed consent to participate in the study.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
A clinical trial for Heart Disease Risk assessment and treatment of patients with high risk.Health Condition 1: I00-I99- Diseases of the circulatory system
CTRI/2019/04/018723Dr Saurabha Nayak
Recruiting
Not Applicable
Study of effect of yoga in reducing cardiovascular disease risks in community
CTRI/2017/09/009770Jawaharlal Institute of Post graduate Medical Education and Research JIPMER1,000
Recruiting
Not Applicable
Validation and adoption of the cardiovascular risk algorithm in arriba for the German general practice setting.I20-I25I63Ischaemic heart diseasesCerebral infarction
DRKS00004633Gemeinnützige Gesellschaft für Patientenzentrierte Kommunikation mbH (GPZK)6,000
Active, not recruiting
Phase 1
CREATE. Cardiovascular Risk Evaluation and Attenuation of inflammation by early rosuvastatin TrEatment - CREATE
EUCTR2006-001860-22-ISKarl Andersen
Not yet recruiting
Not Applicable
Cardiovascular Disease (CVD) Risk Assessment and Lipid Lowering Treatment in Type 2 Diabetes Mellitus Patients Treated at Secondary and/or Tertiary Hospitals in Korea
KCT0004984Pfizer Upjohn Korea2,000